(FOA)-Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed (PAR-20-105); May 6, 2020

 

Agency

U.S. Food and Drug Administration

 

Description

This cooperative agreement is intended to enhance the capacity and capabilities of state human and animal food testing laboratories in support of an integrated food safety system. Specifically, through sample testing in the areas of microbiology, chemistry, and radiochemistry, and the development special projects that would support and expand that testing. This project will strengthen and improve FDA’s efforts to prevent foodborne illnesses and minimize foodborne exposures through building a nationally integrated laboratory science system and equip our partner laboratories with additional resources that can be employed to build and increase sample throughput capacity within their state. 

 

This mechanism includes multiple disciplines and analytical tracks, outlined by the table below:

 

Discipline

Analytical Tracks

Microbiology
  • Food Defense
  • Human Food Product testing
  • Animal Food Product Testing
  • Whole Genome Sequencing
  • Microbiology Capability/ Capacity Development

Chemistry
  • Food Defense
  • Human Food Product testing
  • Animal Food Product Testing
  • Chemistry Capability/ Capacity Development

Radiochemistry
  • Food Defense
  • Radiochemistry Capability/ Capacity Development

Special Projects
  • Sample Collection
  • NFSDX Integration or ORAPP Adoption
  • Method Development and Method Validation

 

Announcement Number:

PAR-20-105

 

Closing Date:

May 6, 2020  

 

Link to Full Announcement

https://grants.nih.gov/grants/guide/pa-files/PAR-20-105.html

 

Contact Information

Erin Woodom-Coleman

240-402-4617

Erin.Woodom-Coleman@fda.hhs.gov